Clario fuses scientific expertise and global scale into the broadest endpoint technology platform for clinical trials to enable pharmaceutical, biotech and medical device partners.
Clario is a leading technology company that generates the richest clinical evidence in the industry for pharmaceutical, biotech and medical device partners. Clario's Trial Anywhere solutions have been powering hybrid and decentralized clinical trials (DCT) for over 15 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving the patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory for over 5m patients in 120 countries.
eCOA
Decentralized Trials
Trial Enablement
Clario CTMS
Clario eTMF (Electronic Trial Master File)
Supercharger evaluates venture outcomes so you don't have to. This offer may not be available if you leave this web page and return later.
Free 14-day Trial
Autonomous ETL for Investors and FIs